Healthcare Sector Drives S&P 500 Higher

A quiet start to the week is expected today on local markets after a dull end to the week globally on Friday night. Eurozone shares were flat on Friday, but the S&P 500 rose 0.2%, helped by health care stocks as President Trump’s plans to try and cut US drug prices fell flat with investors. That saw the overnight ASX 200 futures end 4 points or 0.1% higher which suggests a small gain on the ASX this morning.

The US earnings season continues to wind down this week, with around 10 S&P 500 companies expected to report results - most of those will be retailers, led by the giant Walmart.

On to commodities, and on the whole it was a positive week for commodities with gold, oil, copper, silver and iron ore all enjoying gains. Oil led the way with President Trump’s decision to abandon the Iran nuclear deal leaving prices higher over the week, despite Friday’s slight retreat. US gold futures eased on Friday, but still managed to finish higher over the week as the US dollar eased from recent highs. Comex June gold fell $US1.60, or 0.1%, to settle at $US1,320.70 an ounce in New York. That was a gain of around 0.5% for the week and the first rise in four weeks.  

Data Releases:

-   No Significant Data

To view the Rivkin economic calendar and Local Markets matrix, members can click here.

This article was written by Shannon Rivkin - Investment Director, Rivkin Securities Pty Ltd. Enquiries can be made via or by phoning +612 8302 3633.

Complex product warning

This article contains information about foreign exchange contracts, which are considered complex financial products. Please click here to read ASIC's foreign exchange trading article before considering an investment in foreign exchange contracts. 

This article contains information about CFDs, which are considered complex financial products. Please click here to read ASIC's "Thinking of trading contracts for difference?" document before considering an investment in CFDs.
comments powered by Disqus

DISCLAIMER: Rivkin aims to provide clear and simple information to those visiting our website. If any part of this disclaimer does not make sense, please phone Rivkin and ask to speak with a member of our Dealing and Relationship Management Team. Rivkin provides general advice and dealing services on securities, derivatives and superannuation (SMSF). Rivkin also provide SMSF administration and accounting services. Rivkin does not provide advice that takes into account your, or anybody else's, investment objectives, financial situation or needs. We strongly suggest that you consult an independent, licenced financial advisor before acting upon any information contained on this website. Investing in and trading securities (such as shares listed on the ASX) and/or derivatives (such as Contracts for Difference or 'CFDs') carry financial risks. CFDs carry with them various additional risks that differ from more simple securities such as fully-paid company shares. Some of these risks include not owning the underlying instrument from which a price is being derived, settling trades 'over the counter' with a financial institution rather than on a stock exchange, and using leverage to gain access to trades that may have a higher face value than your initial deposit. This risk of leverage means that it is possible to lose more than your initial investment. Our aim is to create more life choices for our clients, which means improving the wealth of clients throughout many market cycles by nurturing a relationship spanning many years. If you are not comfortable with your understanding of the risks involved before using a Rivkin product and service, please contact our office to seek further information or a Product Disclosure Statement, or make an appointment to sit with one of our friendly financial experts. It is in our interest for your Rivkin experience to be a rewarding and comfortable one. Rivkin is a trading name of Rivkin Securities ABN 87123290602, which holds Australian Financial Services Licence No. 332 802.